Windtree Therapeutics

Windtree Therapeutics Current Liabilities

The Current Liabilities of Windtree Therapeutics (WINT) as of Oct 18, 2026 is 7.67 M USD. In the previous year, Current Liabilities was 6.05 M USD — a change of 26.78% (higher).

Current Liabilities

7.67 MUSD

YoY

26.78%

Last updated:

Current Liabilities of Windtree Therapeutics is 2024 7.67 M USD. Current Liabilities of Windtree Therapeutics was 2023 6.05 M USD. It decreases by 26.78% higher compared to the previous year.

The Windtree Therapeutics Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2017
30.08 M USD
Jan 1, 2018
26.90 M USD
Jan 1, 2019
11.79 M USD
Jan 1, 2020
10.75 M USD
Jan 1, 2021
8.86 M USD
Jan 1, 2022
4.41 M USD
Jan 1, 2023
6.05 M USD
Jan 1, 2024
7.67 M USD
The Windtree Therapeutics Current Liabilities history
YEARCurrent LiabilitiesYoY
7.67 MUSD+26.78%
6.05 MUSD+37.09%
4.41 MUSD-50.19%
8.86 MUSD-17.58%
10.75 MUSD-8.85%
11.79 MUSD-56.16%
26.90 MUSD-10.57%
30.08 MUSD-34.61%
46.00 MUSD+148.85%
18.49 MUSD+32.38%
13.96 MUSD-15.75%
16.57 MUSD+4.06%
15.93 MUSD+12.26%
14.19 MUSD+29.00%
11.00 MUSD-44.57%
19.84 MUSD+12.60%
17.62 MUSD-12.68%
20.18 MUSD+41.05%
14.31 MUSD-48.31%
27.68 MUSD-123.96%
-115.50 MUSD-1,272.83%
9.85 MUSD+53.83%
6.40 MUSD+78.13%
3.59 MUSD-25.11%
4.80 MUSD+221.86%
1.49 MUSD-32.23%
2.20 MUSD+83.33%
1.20 MUSD+183.02%
424,000.00USD-15.20%
500,000.00USD-68.37%
1.58 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Windtree Therapeutics Stock analysis

What does Windtree Therapeutics do? Windtree Therapeutics Inc., based in Warrington, Pennsylvania, operates in the Health Care sector, specifically within Biotechnology. The company develops and manufactures KL4 surfactant therapies for respiratory diseases, focusing on respiratory distress syndrome in premature infants. Its core product, AEROSURF (lucinactant for inhalation), targets non-invasive treatment of respiratory conditions. Windtree employs 14 full-time staff and is listed on the stock market since 1995. Windtree Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Windtree Therapeutics stock

Current Liabilities of Windtree Therapeutics is 7.67 M USD in 2024.

Current Liabilities of Windtree Therapeutics changed from 6.05 M USD to 7.67 M USD, representing a 26.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Windtree Therapeutics since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Windtree Therapeutics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Windtree Therapeutics

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Windtree Therapeutics